Paper Details

  1. Home
  2. Paper Details

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer.

Author: CarrieChristian, KishanAmar U, NguyenPaul L, ParkerChristopher C, StephensonAndrew J, TendulkarRahul D, TranPhuoc T

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Radiation therapy (SRT) is currently the only cure for prostate cancer that has returned after surgery. Key questions include what level of PSA (a marker of prostate cancer) should trigger SRT, and whether hormone therapy (HT) should be used alongside SRT.
Paper Details　
Original Abstract of the Article :
Currently, salvage radiotherapy (SRT) is the only known curative intervention for men with recurrent disease following prostatectomy. Critical issues in the optimal selection and management of men being considered for SRT include the threshold prostate-specific antigen (PSA) value at which to initia...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.euo.2018.02.008

データ提供：米国国立医学図書館（NLM）

Salvage Postprostatectomy Radiotherapy: Optimizing Treatment for Prostate Cancer

Prostate cancer is a common and treatable disease, but managing recurrent disease after prostatectomy poses a challenge. This study delves into the complexities of salvage radiotherapy (SRT) and concurrent hormonal therapy (HT) for men with recurrent prostate cancer after prostatectomy, aiming to optimize treatment strategies.

Balancing Act: Finding the Optimal Time for Salvage Radiotherapy

The study explores the optimal timing for initiating SRT, examining the threshold PSA value at which to begin treatment. The authors also investigate the role of concurrent HT in enhancing the effectiveness of SRT.

A Tailored Approach: Personalized Treatment Strategies for Prostate Cancer

This research highlights the importance of individualized treatment strategies for prostate cancer, emphasizing the need to consider the specific characteristics of each patient's disease and overall health status when making decisions about SRT and HT.

Dr.Camel's Conclusion

This research is like a guide through the desert of prostate cancer treatment, helping clinicians find the most effective path forward for patients with recurrent disease after prostatectomy. The study's findings underscore the importance of careful planning and a personalized approach to optimize treatment outcomes.

Date :
  1. Date Completed 2019-10-02
  2. Date Revised 2021-11-22
Further Info :

Pubmed ID

31100226

DOI: Digital Object Identifier

10.1016/j.euo.2018.02.008

Related Literature

Article Analysis
・Effective treatment of prostate cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.